Skip to content
Home/Companies/MedTech/Nyxoah
Nyxoah

Nyxoah

MedTech·Belgium·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Nyxoah?

Nyxoah is currently owned by Andera Partners through BioDiscovery 5 (2017 vintage), since 2020.

Hand-verified · updated 2026-04-21

Andera Partners
Investor
Andera Partners
BioDiscovery 5 · 2017 · VC

Key facts

HQBelgium
SectorMedTech
Websitenyxoah.com

More from BioDiscovery 5

Other portfolio companies in the same fund.

Amolyt Pharma
Amolyt Pharma
Exited 2024
BiotechFrance· 2021
to
Evommune
Evommune
Exited 2025
BiotechFrance· 2021
to
AgoMab
AgoMab
Exited 2026
BiotechFrance· 2019
to
AM Pharma
AM Pharma
Active
BiotechNetherlands· 2019
Arvelle
Exited 2021
BiotechSwitzerland· 2019
to
Exciva
Active
BiotechUS· 2019

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Nyxoah

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Nyxoah?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Nyxoah.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue